The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Official Title: An Open-Label, Multiple-Dose Extension Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Study ID: NCT02678793
Brief Summary: Subjects who have completed study 4975-MN-202 will be eligible to receive open-label treatment with CNTX-4975 200 µg in study 4975-MN-203 if they meet the inclusion/exclusion criteria.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Arizona Research Center, Phoenix, Arizona, United States
NEA Baptist Clinic, Jonesboro, Arkansas, United States
TriWest Research Associates, LLC, El Cajon, California, United States
Chesapeake Research Group, Pasadena, Maryland, United States
Center for Advanced Medicine & Research, Saint Peters, Missouri, United States
University Orthopedics Center, Altoona, Pennsylvania, United States
University Orthopedics Center, State College, Pennsylvania, United States
Allcare Foot and Ankle Centre, Arlington, Texas, United States
Wasatch Clinical Research, Salt Lake City, Utah, United States
The Education & Research Foundation, Inc., Lynchburg, Virginia, United States